{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:14:12Z","timestamp":1794611652289,"version":"4.9.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of the Report<\/jats:title>\n            <jats:p>Adrenocortical carcinoma (ACC) is an extremely rare endocrine malignancy, which cannot always be diagnosed during conventional radiology and hormonal investigations. <jats:sup>18<\/jats:sup>F-FDG PET could help predict malignancy, but more data are necessary to support future guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cohort of 63 patients with histologically proven ACC (n = 55) or metastatic ACC with steroid oversecretion (n = 8) was assembled. All patients underwent an <jats:sup>18<\/jats:sup>F-FDG PET, and the SUV<jats:sub>max<\/jats:sub> and the adrenal-to-liver SUV<jats:sub>max<\/jats:sub> ratio were calculated. The <jats:sup>18<\/jats:sup>F-FDG PET parameters were compared with clinical, pathological, and outcome data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Fifty-six of 63 patients (89%) had an ACC with an adrenal-to-liver SUV<jats:sub>max<\/jats:sub> ratio &gt;1.45, which was a previously defined cutoff value to predict malignancy with 100% sensitivity. Seven ACCs (11%) had a lower uptake (adrenal-to-liver SUV<jats:sub>max<\/jats:sub> &lt;1.45), most of them with a proliferation marker Ki-67 expression level &lt;10%. A positive correlation between <jats:sup>18<\/jats:sup>F-FDG PET parameters (SUV<jats:sub>max<\/jats:sub> and adrenal-to-liver SUV<jats:sub>max<\/jats:sub> ratio) and tumor size, ENSAT (European Network for the Study of Adrenal Tumors) staging, total Weiss score, and the Ki-67 was found. The strong correlation between SUV<jats:sub>max<\/jats:sub> and Ki-67 (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.47, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0009) suggests a relationship between <jats:sup>18<\/jats:sup>F-FDG uptake levels and tumor proliferation. No statistically significant associations between outcome parameters (progression-free or overall survival) and <jats:sup>18<\/jats:sup>F-FDG PET parameters were found.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This large cohort study shows that most cases of ACC demonstrate high <jats:sup>18<\/jats:sup>F-FDG uptake. However, the positive correlation observed between SUV<jats:sub>max<\/jats:sub> and Ki-67 expression levels seems to explain the possibility of identifying some ACC with a low or inexistent <jats:sup>18<\/jats:sup>F-FDG uptake. These findings have practical implications for the management of patients with an adrenal mass.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004593","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:09:28Z","timestamp":1675987768000},"page":"381-386","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Positive Correlation Between 18F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas"],"prefix":"10.1097","volume":"48","author":[{"given":"Rossella","family":"Lib\u00e9","sequence":"first","affiliation":[{"name":"Service Endocrinologie, French National Network for Adrenal Cancers ENDOCAN-COMETE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Pais","sequence":"additional","affiliation":[{"name":"Service Endocrinologie, French National Network for Adrenal Cancers ENDOCAN-COMETE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Violon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Guignat","sequence":"additional","affiliation":[{"name":"Service Endocrinologie, French National Network for Adrenal Cancers ENDOCAN-COMETE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fideline","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Huillard","sequence":"additional","affiliation":[{"name":"Service d'Oncologie M\u00e9dicale"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Assi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Dousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Gaujoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Barat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Dohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Sibony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Segolene","family":"Cottereau","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Nucl\u00e9aire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tenenbaum","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Nucl\u00e9aire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Groussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","year":"2020","journal-title":"Ann Oncol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00259-019-04553-8","article-title":"Good clinical practice recommendations for the use of PET\/CT in oncology","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis","volume":"175","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1210\/jc.2008-2302","article-title":"18F-fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00268-011-1374-2","article-title":"Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors","volume":"36","year":"2012","journal-title":"World J Surg"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1210\/jc.2017-00254","article-title":"Performance of 18F-FDG PET\/CT in the characterization of adrenal masses in noncancer patients: a prospective study","volume":"102","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"bib10-20250621","first-page":"213875","article-title":"Value of 18-F-FDG PET\/CT and CT in the diagnosis of indeterminate adrenal masses","volume":"2015","year":"2015","journal-title":"Int J Endocrinol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdv329","article-title":"Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumors (ENSAT) study","volume":"26","year":"2015","journal-title":"Ann Oncol"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ando.2008.09.003","article-title":"Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus","volume":"69","year":"2008","journal-title":"Ann Endocrinol (Paris)"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.11100569","article-title":"Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance","volume":"259","year":"2011","journal-title":"Radiology"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1210\/clinem\/dgab005","article-title":"18F-FDG-PET\/CT evaluation of indeterminate adrenal masses in non-cancer patients","volume":"106","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s00268-010-0576-3","article-title":"18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning","volume":"34","year":"2010","journal-title":"World J Surg"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s00259-008-0849-3","article-title":"Does 18F-FDG PET\/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?","volume":"35","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib20-20250621","first-page":"104","article-title":"Use of 18F-FDG\u2013positron emission tomography in presurgical evaluation of nonspecific or suspectious adrenal masses in non-oncologic patients","volume":"146","year":"2016","journal-title":"Med Clin (Barc)"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.suronc.2018.04.003","article-title":"Characterization of adrenocortical tumors by (18)F-FDG PET\/CT: does steroid hormone hypersecretion status modify the uptake pattern?","volume":"27","year":"2018","journal-title":"Surg Oncol"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00268-012-1802-y","article-title":"(18)F-FDG uptake at initial staging of the adrenocortical cancers: a diagnostic tool but not of prognostic value","volume":"37","year":"2013","journal-title":"World J Surg"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"e0129028","DOI":"10.1371\/journal.pone.0129028","article-title":"Correlation between the uptake of 18F-fluorodeoxyglucose (18F-FDG) and the expression of proliferation-associated antigen Ki-67 in cancer patients: a meta-analysis","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"bib24-20250621","first-page":"80","article-title":"Correlation of (18)F-FDG uptake on PET\/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer","volume":"37","year":"2018","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/JTO.0b013e31818307a7","article-title":"Relationship between non\u2013small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index","volume":"3","year":"2008","journal-title":"J Thorac Oncol"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"e17472","DOI":"10.1097\/MD.0000000000017472","article-title":"Associations between FDG-PET and Ki 67-index in head and neck cancer: a meta-analysis","volume":"98","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0973-1482.95182","article-title":"Correlation of fluorodeoxyglucose uptake and tumor-proliferating antigen Ki-67 in lymphomas","volume":"8","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1016\/j.ejca.2012.05.001","article-title":"Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: a systematic review and meta-analysis","volume":"48","year":"2012","journal-title":"Eur J Cancer"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s12020-016-0970-1","article-title":"Assessment of tumor heterogeneity in treatment-naive adrenocortical cancer patients using (18)F-FDG positron emission tomography","volume":"53","year":"2016","journal-title":"Endocrine"},{"key":"bib30-20250621","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1148\/rg.2016150073","article-title":"Malignancies with low fluorodeoxyglucose uptake at PET\/CT: pitfalls and prognostic importance: resident and fellow education feature","volume":"36","year":"2016","journal-title":"Radiographics"},{"key":"bib31-20250621","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/RLU.0000000000004357","article-title":"The concept of strength through synergy applied to the search of powerful prognostic biomarkers in gastroesophageal cancer: an example based on combining clinicopathological parameters, imaging-derived sarcopenia measurements, and radiomic features","volume":"48","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:01:54Z","timestamp":1750532514000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004593","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,8]]}}}